Risk of adverse pregnancy outcomes in women treated for malaria with dihydroartemisinin-piperaquine or quinine in the first trimester of pregnancy in Indonesia: a retrospective data analysis

Slični predmeti

• Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy
  od: Poespoprodjo, JR, i dr.
  Izdano: (2014)
• Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy.
  od: Jeanne Rini Poespoprodjo, i dr.
  Izdano: (2014-01-01)
• Treatment policy change to dihydroartemisinin-piperaquine contributes to the reduction of adverse maternal and pregnancy outcomes
  od: Poespoprodjo, J, i dr.
  Izdano: (2015)
• Piperaquine pharmacokinetics during intermittent preventive treatment for malaria in pregnancy
  od: Chotsiri, P, i dr.
  Izdano: (2021)
• Efficacy and safety of intermittent preventive treatment and intermittent screening and treatment versus single screening and treatment with dihydroartemisinin–piperaquine for the control of malaria in pregnancy in Indonesia: a cluster-randomised, open-label, superiority trial
  od: Ahmed, R, i dr.
  Izdano: (2019)